from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0684/fusA1

LFCtreatmentdescriptionclass of inhibitor

-1.940

Amikacinug/mL Amikacintranslation

-0.005

Cap5-10ug/mL Capreomycintranslation

-0.728

Rox10-50 ug/mL Roxithromycintranslation

1.441

SM2-5 ug/mL Streptomycintranslation

-0.599

Tet5-10 ug/mL Tetracyclinetranslation

-1.137

Rif0.2-5ug/mL Rifampicintranscription

-0.456

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.459

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.549

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.099

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.201

Clofazimine10-13 ug/mL Clofaziminerespiration

0.358

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.648

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.302

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.843

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.245

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.013

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.620

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.502

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.076

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.282

KCN5-20 ug/mL Potassium cyaniderespiration

-0.835

NaN30.2-2 mM Sodium aziderespiration

1.303

Nigericin50 uM Nigericinrespiration

-1.551

TRC10-150 ug/mL Triclosanrespiration

-1.143

TRZ10-25 ug/mL Thioridazinerespiration

1.558

Valinomycin0.5-10 uM Valinomycinrespiration

0.755

ZnSO42 mM ZnSO4respiration

-0.077

menadione6-10 ug/mL Menadionerespiration

0.523

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.744

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.724

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.688

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.183

NRP_1Non-replicating persistence stage 1dosRassociated

0.416

Amp0.2mg/mL AmpicillincellWall

0.529

Cephalexin20-100 ug/mL CephalexincellWall

0.613

Cerulenin0.32-5 ug/mL CerulenincellWall

0.150

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.156

EMB10-20 ug/mL EthambutolcellWall

-0.076

Eta12-40 ug/mL EthionamidecellWall

0.482

INH0.2-0.4 ug/mL IsoniazidcellWall

0.069

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.263

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.785

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.297

BZA0.12 mg/mL BenzamidearomaticAmides

-0.141

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.153

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.059

H2O24 mM hydrogen peroxideDNAdamaging

0.933

Levo10 ug/mL LevofloxacinDNAdamaging

0.822

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.152

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.698

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.195

UVUV-irradiationDNAdamaging

-0.696

ARP41-4 ug/mL Antitubercular compound ARP4?

0.591

Antimycin12.5-50 ug/mL Antimycin A?

0.777

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.724

PA_110-50 ug/mL Antitubercular compound PA-1?

0.736

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.738

PA8240.2-2 ug/mL PA-824?

-0.416

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.587

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.718

Verapamil50 uM Verapamil?

0.313

mercaptoethanol2 mM 2-Mercaptoethanol?

0.993

methoxatin10-20 ug/mL Methoxatin?